Literature DB >> 2876136

Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire.

J M Mann, H Francis, F Davachi, P Baudoux, T C Quinn, N Nzilambi, N Bosenge, R L Colebunders, P Piot, N Kabote.   

Abstract

A prevalence study of antibody to human immunodeficiency virus (HIV) was conducted in Kinshasa, Zaïre, among 258 children 2-24 months old who were in hospital, 191 children 1-20 months old who were attending a well-child clinic, and their mothers. 8% of the mothers of both groups of children were seropositive. Among children under 9 months old, 12 of 102 (12%) hospital inpatients and 11 of 136 (8%) clinic attenders were seropositive, while in the 9-24-month age group 20 of 156 (13%) hospital children and only 1 of 55 (2%) clinic children were seropositive (Fisher's exact test, p = 0.01). 61% of the seropositive children had seropositive mothers, indicating a high rate of vertical transmission. Factors associated with seropositivity among hospital children with seronegative mothers included male sex, increased lifetime number of medical injections, and previous blood transfusion or hospital admission. Among children who had not previously been transfused or admitted to hospital the seropositives had received more medical injections than the seronegatives (median 34.5 versus 14.5; Wilcoxon rank sum test, p = 0.006). HIV infection accounted for or complicated a substantial proportion of hospital paediatric admissions. Public health measures are urgently required to prevent parenteral and vertical transmission of HIV to infants and young children in Kinshasa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876136     DOI: 10.1016/s0140-6736(86)90167-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

Review 1.  Central nervous system pathology in children with AIDS. A review.

Authors:  C Keohane; F Gray
Journal:  Ir J Med Sci       Date:  1991-09       Impact factor: 1.568

Review 2.  A review of HIV-1 in Africa.

Authors:  A R Ronald; J O Ndinya-Achola; F A Plummer; J N Simonsen; D W Cameron; E N Ngugi; H Pamba
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

3.  The clinical features of HIV infection in Africa.

Authors:  R J Biggar
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

4.  HIV infection and maternal and child health.

Authors:  P Ramachandran
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

Review 5.  Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.

Authors:  B Aylward; J Lloyd; M Zaffran; R McNair-Scott; P Evans
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

7.  Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire.

Authors:  P Nguyen-Dinh; A E Greenberg; J M Mann; N Kabote; H Francis; R L Colebunders; A Y Huong; T C Quinn; F Davachi; B Lyamba
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 8.  Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health Organization.

Authors:  D J Hu; M A Kane; D L Heymann
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

9.  Risk factors for infection with human immmunodeficiency virus among European expatriates in Africa.

Authors:  L Bonneux; P Van der Stuyft; H Taelman; P Cornet; C Goilav; G van der Groen; P Piot
Journal:  BMJ       Date:  1988-09-03

10.  Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries.

Authors:  P Van de Perre; D Nzaramba; S Allen; C H Riggin; S Sprecher-Goldberger; J P Butzler
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.